Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure

Circulation

Volumn 103, Issue 17, 2001, Pages 2195-2200

  Dalla Libera, Luciano ^a   Ravara, Barbara ^a   Angelini, Annalisa ^a   Rossini, Katia ^a   Sandri, Marco ^a   Thiene, Gaetano ^a   Ambrosio, Giovanni Battista ^b   Vescovo, Giorgio ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b City Hospital   (Italy)

Author keywords

Apoptosis; Heart failure; Irbesartan; Muscles; Tumor necrosis factor

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CASPASE 3; CASPASE 9; IRBESARTAN; MONOCROTALINE; NIFEDIPINE; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HEART FAILURE; HEART MUSCLE CELL; NICK END LABELING; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; TIBIALIS ANTERIOR MUSCLE;

EID: 0035337178     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.17.2195     Document Type: Article

References (33)

1. Lipkin D, Jones D, Round J, et al. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardial. 1988;18:187-195.
2. Mancini DM, Reichek N, Chance B, et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation. 1992;85:1364-1373.
3. Vescovo G, Serafini F, Facchin L, et al. Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis. Heart. 1996;76:337-343.
4. Vescovo G, Dalla Libera L, Serafini F, et al. Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition. Circulation. 1998;98:1742-1749.
5. Dalla Libera L, Zennaro R, Sandri M, et al. Apoptosis and atrophy in rat slow skeletal muscles in chronic heart failure. Am J Physiol. 1999;277: C982-C986.
6. Simonini A, Long CS, Dudley GA, et al. Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity. Circ Res. 1996;79:128-136.
7. Vescovo G, Zennaro R, Sandri M, et al. Apoptosis of skeletal muscle myofibers and interstitial cells in experimental heart failure. J Mol Cell Cardiol. 1998;30:2449-2459.
8. Vescovo G, Volterrani M, Zennaro R, et al. Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. Heart. 2000;84:431-437.
9. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med. 1997;336:1131-1141.
10. Krown KA, Page MT, Nguyen C, et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest. 1996;98: 2854-2865.
11. Kajstura J, Cigola E, Malhotra A, et al. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol. 1997;29: 859-870.
12. Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA. 1996;93:156-160.
13. Li W, Ye Y, Fu B, et al. Genetic deletion of AT2 receptor antagonizes angiotensin II-induced apoptosis in fibroblasts of the mouse embryo. Biochem Biophys Res Commun. 1998;250:72-76.
14. Fortuno MA, Ravassa S, Etayo JC, et al. Overexpression of Bax protein and enhanced apoptosis in the left ventricle of spontaneously hypertensive rats: effects of ATI blockade with Iosartan. Hypertension. 1998; 32:280-286.
15. Li Z, Bing OH, Long X, et al. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol. 1997;272:H2313-H319.
16. Vescovo G, Jones SM, Harding SE, et al. Isoproterenol of isolated cardiac myocytes from rats with monocrotaline-induced right-sided hypertrophy and cardiac failure. J Mol Cell Cardiol. 1989;21:1047-1061.
17. Culman J, Von Heyer C, Piepenburg B, et al. Effects of systemic treatment with irbesartan and Iosartan on central responses to angiotensin II in conscious, normotensive rats. Eur J Pharmacol. 1999;367:255-265.
18. Sandri M, Carraro U, Podhorska-Okolov M, et al. Apoptosis, DNA damage and ubiquitin expression in normal and mdx muscle fibers after exercise. FEBS Lett. 1995;1995:373:291-295.
19. Allen DL, Linderman JK, Roy RR, et al. Apoptosis: a mechanism contributing to remodeling of skeletal muscle in response to hindlimb unweighting. Am J Physiol. 1997;273:C579-C587.
20. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281: 1309-1312.
21. Ferrari R, Bachetti T, Confortini R, et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation. 1995;92:1479-1486.
22. Deswal A, Bozkurt B, Seta Y, et al Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel Etanercept) in patients with advanced heart failure. Circulation. 1999;99:3224-3226.
23. Oral H, Dorn GW II, Mann DL. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor alpha in the adult mammalian cardiac myocyte. J Biol Chem. 1997;272:4836-4842.
24. Sabbadini RP, Danieli-Betto D, Betto R. The role of shingolipids in the control of skeletal muscle function: a review. Ital J Neurol Sci. 1999;20: 423-430.
25. Lehtonen JY, Daviet L, Nahmias C, et al. Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis. Mol Endocrinol. 1999;13:1051-1060.
26. Li D, Tomson K, Yang B, et al. Modulation of constitutive nitric oxide synthase, bcl-2 and Fas expression in cultured human coronary endothelial cells exposed to anoxia-reoxygenation and angiotensin II: role of ATI receptor activation. Cardiovasc Res. 1999;41:109-115.
27. Li D, Yang B, Philips MI, et al. Proapoptotic effects of ANG II in human coronary artery endothelial cells: role of ATI receptor and PKC activation. Am J Physiol. 1999;276:H786-H792.
28. Leri A, Liu Y, Claudio PP, et al. Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis. Am J Patliol. 1999; 154:567-580.
29. Leri A, Liu Y, Li B, et al. Up-regulation of ATI and AT2 receptors in post-infarcted hypertrophied myocytes and strelched-mediated apoptotic cell death. Am J Pathol. 2000;156:1663-1672.
30. 1) receptor-mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo. Hypertension. 1997;30:42-49.
31. Malendowicz SL, Ennezat PV, Testa M, et al. Angiotensin II receptor subtypes in the skeletal muscle vasculature of patients with severe congestive heart failure. Circulation. 2000;102:2210-2213.
32. Tamura K, Umemura S, Nyui N, et al. Tissue-specific regulation of angiotensinogen gene expression in spontaneously hypertensive rats. Hypertension. 1996;27:1216-1223.
33. Coats AJS, Clark AL, Piepoli M, et al. Symptoms and quality of life in heart failure: the muscle hypothesis. Br Heart J. 1994;72:36-39.